TECH AND health care have a fraught relationship. On January 3rd Elizabeth Holmes, founder of Theranos, a startup that once epitomised the promise of combining Silicon Valley’s dynamism with a stodgy health-care market, was convicted of lying to investors about the capabilities of her firm’s blood-testing technology. Yet look beyond Theranos, which began to implode way back in 2015, and a much healthier story becomes apparent. This week a hoard of entrepreneurs and investors will gather virtually at the annual JPMorgan Chase health-care jamboree. The talk is likely to be of AI, digital diagnostics and tele-health— and of a new wave of capital flooding into a vast industry.
Clunky, costly,
→ Continue reading at The Economist
